Larimar Therapeutics Inc.

Larimar Therapeutics is a clinical-stage biotechnology company dedicated to developing treatments for complex rare diseases. Their core technology is a proprietary intracellular delivery platform designed to deliver proteins and other molecules directly inside cells. Their lead product candidate, nomlabofusp, is a recombinant fusion protein intended to deliver human frataxin to the mitochondria of patients with Friedreich's ataxia (FA), a rare and progressive genetic disease. Nomlabofusp has received various designations from the FDA and EMA, indicating its potential for significant impact on patients with FA.

Larimar Therapeutics is headquartered in the Philadelphia area and offers a competitive benefits package to its employees. Their focus on collaboration, creativity, and rigor in their approach to developing treatments for rare diseases is reflected in their partnerships with organizations like the Friedreich's Ataxia Research Alliance (FARA) and Wake Forest Innovations. They are committed to attracting and retaining talented individuals who share their passion for making a difference in the lives of patients with rare diseases.

Larimar Therapeutics offers a competitive benefits package that includes comprehensive medical, dental, and vision insurance plans, along with a 401(k) retirement savings plan with a company match.

Larimar Therapeutics is a clinical-stage biotechnology company dedicated to developing treatments for patients with complex rare diseases. They focus on discovering and developing therapies for these diseases, with an initial focus on Friedreich's ataxia, using their proprietary protein replacement therapy platform. Their goal is to deliver missing proteins inside cells to address the root cause of these devastating rare diseases, providing hope for patients with limited or no existing treatment options.

Larimar Therapeutics emphasizes a collaborative, creative, and rigorous work environment. The company values open communication, integrity, work-life balance, employee empowerment, and growth opportunities, all in pursuit of developing treatments that improve the lives of patients with rare diseases.

Larimar Therapeutics is committed to fostering a diverse, equitable, and inclusive workplace. They actively seek to build a team that reflects the diversity of the communities they serve, recognizing the value of different perspectives and backgrounds. This commitment is demonstrated through their dedication to fair hiring practices, offering a competitive benefits package, and cultivating a culture that values open communication, integrity, and work-life balance.